Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, ...

ICSE board has released the official syllabus for classes 9 to 12 to help students prepare for the board exams. Students can ...

Approval of pediatric strategy validates clinical data package and accelerates the regulatory path for CORDStrom™ in the United KingdomBOCA ...

Global Contract Development and Manufacturing Organizations (CDMOs) are employing divergent investment strategies to seize ...

The company recorded a full $16.5 million impairment of an intangible asset due to the Alzheimer's trial not meeting the clinical endpoint. Cory Ellspermann noted the net loss increased to $45.9 ...

AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a ...

Approval of pediatric strategy validates clinical data package and accelerates the regulatory path for CORDStrom in the United Kingdom BOCA RATON, Fla, June 25, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc ...

Hormones—including androgens, estrogen, and cortisol—play a major role in hair growth and hair loss over time.

(NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE ® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the ...

When circadian rhythms are disrupted (from shift work, frequent travel, irregular sleep schedules, or excessive nighttime ...

The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally ...

Improves Antibody Yield by About 10% in the Purification ProcessJune 16, 2026 -- FUJIFILM Corporation (President and CEO, ...